Revium Rx (RVRC) Shares Outstanding (Weighted Average) (2024 - 2025)
Revium Rx's (RVRC) quarterly Shares Outstanding (Weighted Average) came in at $60.7 million in Q4 2025, up 4.83% year-on-year from $57.9 million in Q4 2024, and up 4.83% quarter-over-quarter from $57.9 million in Q4 2024.
Revium Rx (RVRC) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Shares Outstanding (Weighted Average) across 2 years of filings, most recently posting $60.7 million for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $60.7 million, up 4.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $60.7 million (up 4.83% YoY), and the FY2025 annual result was $60.7 million, up 4.83% from the prior year.
- Shares Outstanding (Weighted Average) came in at $60.7 million for Q4 2025 at Revium Rx, up from $57.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $60.7 million in Q4 2025 to a low of $57.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 163.35 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 204.71 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 84.41 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 78.62 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 128.29 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 187.01 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 191.67 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 124.15 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 45.32 Mn |
| 10 | Revium Rx | - | - | - | 60.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 57.93 Mn |